Skip to main content
Home
Loading...
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube

Menu top

  • Assistance

User account menu

  • Log in
Home

Main navigation

  • Home
  • Programme
Menu Login
Close

Main navigation mobile

  • Home
  • Programme

Menu top

  • Assistance
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube
Filters
Filters Close
Poster topics
  • Allergy diagnosis (1)
  • Epidemiology (5)
  • Immune deficiencies and autoimmunity (8)
Poster available until
  • Until platform closure (7)
Poster categories
  • Thematic Poster Session (15)
keywords
Session Reference
  • L-TPS01 (11)
  • L-TPS02 (15)
  • L-TPS03 (14)
  • L-TPS04 (12)
  • L-TPS05 (13)
  • L-TPS06 (8)
  • L-TPS07 (11)
  • L-TPS08 (7)
  • L-TPS09 (13)
  • L-TPS10 (13)
  • L-TPS11 (12)
  • L-TPS12 (14)
  • L-TPS13 (13)
  • L-TPS14 (11)
  • L-TPS15 (7)
  • L-TPS16 (14)
  • L-TPS17 (13)
  • L-TPS18 (10)
  • L-TPS19 (10)
  • L-TPS20 (12)
  • L-TPS21 (12)
  • TPS01 (12)
  • TPS02 (8)
  • TPS03 (14)
  • TPS04 (9)
  • TPS05 (15)
  • TPS06 (11)
  • TPS07 (13)
  • TPS08 (9)
  • TPS09 (9)
  • TPS10 (16)
  • TPS11 (13)
  • TPS12 (12)
  • TPS13 (11)
  • TPS14 (12)
  • TPS15 (15)
  • TPS16 (15)
  • TPS17 (12)
  • TPS18 (10)
  • TPS19 (7)
  • TPS20 (11)
  • TPS21 (5)
  • TPS22 (3)
  • TPS23 (4)
  • TPS25 (12)
  • TPS26 (14)
  • TPS27 (12)
  • TPS28 (16)
  • TPS29 (16)
  • TPS30 (14)
  • TPS31 (15)
  • TPS32 (16)
  • TPS33 (14)
  • TPS34 (17)
  • TPS35 (15)
  • TPS36 (12)
  • TPS37 (15)
  • TPS38 (13)
  • TPS39 (14)
  • TPS40 (13)
  • TPS41 (9)
  • TPS42 (12)
  • TPS43 (12)
  • TPS44 (14)
  • TPS45 (12)
  • x TPS46 (8)
  • TPS47 (7)
  • TPS48 (5)
  • TPS49 (5)
  • TPS51 (12)
  • TPS52 (14)
  • TPS53 (8)
  • TPS54 (15)
  • TPS55 (13)
  • TPS56 (16)
  • TPS57 (12)
  • TPS58 (12)
  • TPS59 (13)
  • TPS60 (14)
  • TPS61 (11)
  • TPS62 (9)
  • TPS63 (10)
  • TPS64 (11)
  • x TPS65 (8)
  • TPS66 (9)
  • TPS67 (9)
  • TPS68 (19)
  • TPS69 (8)
  • TPS70 (9)
  • TPS71 (11)
  • TPS72 (6)
  • TPS73 (5)
  • TPS75 (4)
16 results
Thumbnail

D2.415 - Application of magnetic particle chemiluminescence technology to detect sensitization in patients in Guangzhou, China: a study base on real-world medical data

Thumbnail

D2.419 - Quality of life and measures of well-being of Canadian patients with HAE C1-INH based on data from the 2020 and 2024 national surveys

Thumbnail

D2.420 - Sensitization Profile of Lipocalins: sIgE Analysis in a Large Cohort of Patients with Suspected Allergies

Thumbnail

D2.413 - Association of sensitization to fur animal allergens and Bet v 1 in the Russian population

Thumbnail

D2.414 - Trends in the prevalence of asthma in Korean children: a population-based study from 1995 to 2022

Thumbnail

D2.416 - Online Education Significantly Improves Physicians’ Knowledge of Novel Long-Term Prophylaxis Therapies for Hereditary Angioedema

Thumbnail

D2.417 - Research transparency, reproducibility and accessibility in Allergy, 2003 – 2023: Preliminary results of the TRACES study

Thumbnail

D2.418 - Risk Factors for Severe Allergic Rhinitis and the Association with Serum sIgE Levels: A Study in Guangzhou, China

Thumbnail

- D1.323 - Clinical Experience with Lanadelumab for Hereditary Angioedema in Kazakhstan

Thumbnail

D3.317 - Moderate-to-severe infections and initial SELENA-SLEDAI correlate with the incidence of flares in patients with Systemic Lupus Erythematosus

Thumbnail

D3.322 - Acquired chronic granulomatous disease secondary to myelodysplastic disorder

Thumbnail

D3.324 - Mastoiditis as complication of Hyper IgM syndrome

Thumbnail

D3.326 - A RARE COEXISTENCE: CARD9 DEFICIENCY AND IgG4-RELATED DISEASE IN A PEDIATRIC PATIENT

Thumbnail

D3.327 - Use of C1 Inhibitor Subcutaneously in the United Kingdom

Thumbnail

D3.328 - Relapsing COVID-19 pneumonia and Helicobacter cineadi cellulitis in a patient with X-linked agammaglobulinemia

Thumbnail

D3.332 - Determination of Reference Intervals for IgG, IgA, and IgM Levels by Age in Healthy Adults

Download the app
The congress at your fingertips

Available on

App Store Google Play
QR Code Download
Mobile App Schedule page
Mobile App Home page
Menu social network
  • LinkedIn
  • Facebook
  • X
  • Youtube
© 2025 EAACI
Made with   by CYIM